Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Repeat Dose Study of the Dexmedetomidine Transdermal System in Healthy Subjects

NCT07818330 is registered in ClinicalTrials.gov with Teikoku Pharma USA, Inc. as lead sponsor.

NCT NCT07818330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07818330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Repeat Dose Study of the Dexmedetomidine Transdermal System in Healthy Subjects
Lead sponsor
Teikoku Pharma USA, Inc.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 30, 2026
Completion date
December 23, 2026
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects